Ingenus Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INGENUS PHARMS LLC
INGENUS PHARMS LLC has sixty approved drugs.
Drugs and US Patents for Ingenus Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingenus Pharms Llc | MEXILETINE HYDROCHLORIDE | mexiletine hydrochloride | CAPSULE;ORAL | 214352-002 | Jan 25, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ingenus Pharms Llc | AMPHETAMINE SULFATE | amphetamine sulfate | TABLET;ORAL | 213763-002 | Aug 24, 2020 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Ingenus Pharms Llc | TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | CAPSULE;ORAL | 210267-001 | Mar 12, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ingenus Pharms Llc | LEUCOVORIN CALCIUM | leucovorin calcium | TABLET;ORAL | 211132-002 | Jul 30, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ingenus Pharms Llc | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 207562-002 | Oct 16, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

